ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.
about
Hepatic arterial embolization in patients with neuroendocrine tumorsENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromesThe pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumorsNeuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive ReviewTreatment of neuroendocrine tumors: new recommendations based on the CLARINET studySurgical approaches for liver metastases in carcinoid tumorsPI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasmsSurgical treatment of liver metastases in patients with neuroendocrine tumorsUpdate on surgical treatment of pancreatic neuroendocrine neoplasmsPET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literaturePulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoidsManagement of patients with hepatic metastases from neuroendocrine tumorsLiver transplantation for hepatic tumors: a systematic reviewEmergency therapy for liver metastases from advanced VIPoma: surgery or transarterial chemoembolization?Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumoursStreptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms--Predictive and Prognostic Markers for Treatment StratificationGastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis.Surgical resection improves the outcome of the patients with neuroendocrine tumor liver metastases: large data from AsiaHigh clinical and morphologic response using 90Y-DOTA-octreotate sequenced with 177Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumours.Liver transplantation for malignancy: current treatment strategies and future perspectives.Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems.Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?Efficacy of peptide receptor radionuclide therapy with 177Lu-octreotate in metastatic pulmonary neuroendocrine tumors: a dual-centre analysis.Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature.Radioembolization of hepatic tumorsPancreastatin predicts survival in neuroendocrine tumors.Quality assessment of clinical practice guidelines on the treatment of hepatocellular carcinoma or metastatic liver cancerComprehensive treatment of a functional pancreatic neuroendocrine tumor with multifocal liver metastases.Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.Therapy for metastatic pancreatic neuroendocrine tumors.Practical management and treatment of pancreatic neuroendocrine tumors.Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advancesGene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumorsEvaluation of the WHO 2010 grading and AJCC/UICC staging systems in prognostic behavior of intestinal neuroendocrine tumorsWhen should a liver resection be performed in patients with liver metastases from neuroendocrine tumours? A systematic review with practice recommendationsRole of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference.Transplantation and surgical strategies in patients with neuroendocrine liver metastases: protocol of four systematic reviews.Diagnosis and prediction of neuroendocrine liver metastases: a protocol of six systematic reviews.
P2860
Q21198838-E14F1187-A869-440D-8654-4611C2190D31Q24603675-88529DBF-B479-40F0-A921-DDB4C88D90F0Q26740374-236A5C4B-B91D-4BC5-AABC-472D599E87FFQ26768483-A6EC6F84-4EA6-4537-83E7-6E11BD717B1FQ26770479-9D08C037-2347-4C63-B385-332333B7FC54Q26783232-84A20CF5-7ED7-4ABB-96B1-C521D8CD09A0Q26862544-21B6FF83-FD0D-4968-BA41-67BF8130E872Q26864072-D7328CB4-2BC8-4782-BD68-51E8C323FB44Q26864361-4FD0DD2A-9EEC-4C19-A4EE-BA0E0F30A5D5Q26992201-A1DED7F1-75F7-464B-9264-B29F36F02897Q26996521-BE406850-6691-4AEA-895C-2DA235287416Q27008832-E23F7839-5879-4CE5-9E66-836FA1D91854Q27021650-C322DA0B-85BD-43A8-84A4-27CEE6833505Q28078948-A8398A79-2B30-41E4-A27C-3D3874DA918EQ28247667-FED33DEE-ED1F-4503-AD02-3FF8B91640B2Q28551275-54BBA78D-0D63-4558-907F-E3487C2380FCQ30249051-A1A74319-6CFB-4D22-8F3A-BC1EC04DC6FBQ30252389-53D89168-8141-473E-83BA-A041F23451B4Q30884528-E5F8C41B-8F41-48E2-B015-3AC1B503C75AQ33435622-8EAB946D-C2E7-4F04-AF29-3CF8908365BEQ33594868-9B8CC5B6-8AEF-4D6D-A976-8A58F8E3D595Q33656484-B4F0DCC6-9772-430D-AA2D-4BB8E90AF039Q33658301-5907948F-E98F-46CF-8282-549611792373Q33700134-2A836AE2-66E4-43DF-AC5C-68E53731005DQ33737587-AD1B58D5-C0EA-44F3-9C68-F8889217A8E6Q33820777-AE54E461-17AB-4D9D-990E-94F08F197E57Q34016884-D7A32AB8-CBC2-47BA-AC59-84EAC1B0099AQ34020339-00FE81E8-F304-437A-BA23-71FEA46B7624Q34130243-A1DA85BD-1553-46AA-A6E4-C16A91C55285Q34157385-B6C90F80-B9EC-4350-8E7C-2DD4406F71CCQ34248466-28266B96-987E-452E-8133-5DFA34142903Q34357869-D6364A23-0144-4D24-8B35-AB2DD64FDD90Q34573600-48086FFD-7989-4BF3-A7D5-28FA888FA4FCQ34650411-B75F3421-F90B-4558-B872-EAE090DC5E7CQ34680094-AA78AE36-56C8-4970-9A2E-1A6F28BE640FQ34688938-96B3CA9D-5633-49C3-8924-4B2634337D9EQ34702055-1C67EC5D-8186-4446-825F-BE0B800DC2D2Q34702065-C33DEC84-050E-413B-A4B3-042C37827AE5Q35074937-8CFA628F-48AC-456A-BE5D-F64967F276CAQ35074944-7B2DF3DD-D9DB-401B-8730-262A912BFAEA
P2860
ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
ENETS Consensus Guidelines for ...... hindgut, and unknown primary.
@ast
ENETS Consensus Guidelines for ...... hindgut, and unknown primary.
@en
ENETS Consensus Guidelines for ...... hindgut, and unknown primary.
@nl
type
label
ENETS Consensus Guidelines for ...... hindgut, and unknown primary.
@ast
ENETS Consensus Guidelines for ...... hindgut, and unknown primary.
@en
ENETS Consensus Guidelines for ...... hindgut, and unknown primary.
@nl
prefLabel
ENETS Consensus Guidelines for ...... hindgut, and unknown primary.
@ast
ENETS Consensus Guidelines for ...... hindgut, and unknown primary.
@en
ENETS Consensus Guidelines for ...... hindgut, and unknown primary.
@nl
P2093
P2860
P356
P1433
P1476
ENETS Consensus Guidelines for ...... hindgut, and unknown primary.
@en
P2093
Anne Couvelard
Barcelona Consensus Conference participants
Eric Baudin
Eric Krenning
Kjell Öberg
Marianne Pavel
Martin Anlauf
Ramon Salazar
Thomas Steinmüller
P2860
P304
P356
10.1159/000335597
P577
2012-02-15T00:00:00Z